Medicare Enrolled
Dr. Arun Agarwal, M.D.
Pulmonary Disease · Brewster, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Agarwal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Agarwal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Agarwal
Dr. Arun Agarwal is a pulmonary disease specialist in Brewster, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Agarwal performed 2,829 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Agarwal received a total of $161,039 from 56 pharmaceutical and/or device companies across 615 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Agarwal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 14% volume in NY
$161,039 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,829
Medicare services
Top 14% in NY for pulmonary disease
Not available
Unique patients (not deduplicated)
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,046 | $101 | $368 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
519 | $71 | $259 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
172 | $8 | $12 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
140 | $68 | $198 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
130 | $7 | $245 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
129 | $9 | $200 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
127 | $10 | $176 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
78 | $86 | $333 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $141 | $504 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
74 | $107 | $376 |
| Initial nursing facility care, moderate complexity Initial care provided to a patient in a nursing facility with moderate medical decision making, taking at least 35 minutes. |
65 | $119 | $359 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
61 | $103 | $381 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
46 | $67 | $192 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
45 | $156 | $512 |
| New patient office visit, complex (60-74 min) | 37 | $182 | $626 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
32 | $90 | $1,257 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
28 | $148 | $553 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
22 | $70 | $260 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$161,039
Total received (2018-2024)
Avg $23,006/year across 7 years
Top 3% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
615
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$35,058
2023
$34,810
2022
$38,468
2021
$14,261
2020
$2,472
2019
$18,404
2018
$17,566
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$34,031
Grifols USA, LLC
$990
Alnylam Pharmaceuticals Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$101,420
Grifols USA, LLC
$31,526
Genentech USA, Inc.
$11,431
Boehringer Ingelheim Pharmaceuticals, Inc.
$6,909
Amgen Inc.
$3,192
GlaxoSmithKline, LLC.
$1,712
Grifols Shared Services North America, Inc.
$660
Janssen Pharmaceuticals, Inc
$475
GENZYME CORPORATION
$373
Insmed, Inc.
$294
HARMONY BIOSCIENCES LLC
$255
Novartis Pharmaceuticals Corporation
$217
Regeneron Healthcare Solutions, Inc.
$213
Harmony Biosciences LLC
$176
Shire North American Group Inc
$176
Genentech, Inc.
$125
Radius Health, Inc.
$120
United Therapeutics Corporation
$100
Avanir Pharmaceuticals, Inc.
$99
Amarin Pharma Inc.
$94
Veran Medical Technologies, Inc.
$93
PFIZER INC.
$89
JAZZ PHARMACEUTICALS INC.
$79
Kowa Pharmaceuticals America, Inc.
$69
Pulmonx Corporation
$67
Teva Pharmaceuticals USA, Inc.
$66
Mallinckrodt Hospital Products Inc.
$65
Corcept Therapeutics
$62
Jazz Pharmaceuticals Inc.
$62
Abbott Laboratories
$55
Takeda Pharmaceuticals U.S.A., Inc.
$55
Lundbeck LLC
$52
Philips Electronics North America Corporation
$52
ARBOR PHARMACEUTICALS, INC.
$48
Aurinia Pharma U.S., Inc.
$48
Electromed, Inc.
$45
Merck Sharp & Dohme Corporation
$38
Novo Nordisk Inc
$36
Bayer HealthCare Pharmaceuticals Inc.
$35
Impulse Dynamics (USA) Inc.
$35
Mannkind Corporation
$33
Arbor Pharmaceuticals, Inc.
$28
Sunovion Pharmaceuticals Inc.
$26
Mylan Specialty L.P.
$22
Alnylam Pharmaceuticals Inc.
$20
IBSA Pharma Inc.
$20
MannKind Corporation
$20
Insulet Corporation
$20
Astellas Pharma US Inc
$19
Akcea Therapeutics, Inc.
$18
ADVANCED RESPIRATORY, INC
$18
TherapeuticsMD, Inc.
$16
AbbVie, Inc.
$16
Vanda Pharmaceuticals Inc.
$15
AKEBIA THERAPEUTICS INC
$15
OPKO Pharmaceuticals, LLC
$14
Top 3 companies account for 89.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AFREZZA · ANORO · ANORO ELLIPTA · AirDuo Digihaler · Arikayce · Auryxia · BEVESPI AEROSPHERE · BOOSTRIX · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · CHANTIX · CINQAIR · CardioMEMS HF System · DUPIXENT · ELIQUIS · Edarbi · Esbriet · FARXIGA · FASENRA · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GLASSIA · HETLIOZ · IMVEXXY · INVOKANA · JANUVIA · JARDIANCE · KEVZARA · Kerendia · Korlym · LOKELMA · LONHALA MAGNAIR · LUPKYNIS · Livalo · MYRBETRIQ · NATPARA · NORTHERA · NUCALA · NUEDEXTA · OFEV · OPTIMIZER · Omnipod · Ozempic · PREVNAR - 13 · Prolastin-C · Prolastin-C Liquid · Prolia · Pulmonx Endobronchial Valve EBV · RAYALDEE · SMARTVEST · SPIRIVA · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Synthroid · TEGSEDI · TEZSPIRE · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · Tirosint · Tresiba · Tymlos · Utibron · Vascepa · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xembify · Xolair · Yupelri · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
59
County median income
$127,405
Nearest hospital to ZIP centroid (approximate)
PUTNAM HOSPITAL CENTER
6.5 mi
6.5 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Agarwal is a clinical cardiology specialist, with above-average Medicare volume (top 14% in NY), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Agarwal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Agarwal performed 1,046 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Agarwal receive payments from pharmaceutical companies?
Yes. Dr. Agarwal received a total of $161,039 from 56 companies across 615 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Agarwal's costs compare to other pulmonary diseases in Brewster?
Dr. Agarwal's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Agarwal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Brewster
Browse pulmonary diseases in Brewster ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Grifols USA, LLC Payments to Doctors
See all physicians who received payments from Grifols USA, LLC.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology